Exosomes are extracellular nanoparticles (30-150 nm) in size which are present in almost all body fluids such as serum, milk, urine, and cerebral spinal fluids.
Exosomes originate from different cells and transfer functional cargos like miRNA and mRNA molecules, peptides, and proteins to the recipient cells.
Exosomes are powerful cellular communication traffickers that are being used to power today’s therapeutics applications for drug/siRNA/vaccine delivery and biomarker discovery.
Recently Exom BioPharma has recently isolated a novel exosome from healthy food source (named as Q5 Exosomes) which has several advantages as a drug delivery vehicle over stem cells and milk derived exosomes.
Exom Biopharma also provides various innovative kits and reagents for exosome research. For biomarker discovery, we also provide normal and disease specific exosomes from saliva, urine and blood.
Synthetic liposomes & lipid nanoparticle-based systems are toxic.
Stem cell derived exosomes are expensive and time consuming to manufacture
Bovine milk derived exosomes (recently licensed by Roche for $1B) are also time consuming to isolate and illicit immune response Q5 exosomes are isolated from FDA approved healthy food source.
Q5 exosomes are not toxic, non-immunogenic, and more stable than bovine milk exosomes.
Q5 exosomes are easy to manufacture in large quantities using in-house proprietary technology
Potential delivery vehicle for various drugs/siRNA and vaccines for the treatment of Cancer, Diabetes, Cardiovascular, GI, Parkinson, Alzheimer, etc.
Manufacturing dermatology related products such as wound healing, anti-aging, anti-wrinkle, and anti-inflammatory products